Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Opus Genetics Stock Price, Quotes and Forecasts | NASDAQ:IRD | Benzinga

Q: What sector and industry does Opus Genetics (IRD) operate in?

Opus Genetics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Explore Opus Genetics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IRD.

Open	$0.70
Close	$0.82
Volume / Avg.	129.20K / 209.92K
Day Range	$0.70 - $0.83
52 Wk Range	0.65 - 1.56
Market Cap	$35.15M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	0.31%
Days to Cover	1

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.70
Close	$0.82
Volume / Avg.	129.20K / 209.92K
Day Range	$0.70 - $0.83
52 Wk Range	0.65 - 1.56
Market Cap	$35.15M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	0.31%
Days to Cover	1

About Opus Genetics Inc.

Sector

Health Care

Industry

Pharmaceuticals

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to t...

Got Questions? Ask

What are analysts' targets for IRD?

What does IRD's DCF valuation show?

What is IRD's 7 days volume trend?

What is IRD's net income trend?

What’s driving IRD's recent performance?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Opus Genetics (IRD) stock?

You can purchase shares of Opus Genetics (NASDAQ:IRD) through any online brokerage.

View our list of the best stock brokerages

Who are Opus Genetics (IRD) competitors?

Other companies in Opus Genetics’s space includes: Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Rani Therapeutics Hldgs (NASDAQ:RANI) and Nutriband (NASDAQ:NTRB).

What is the forecast, or price target, for Opus Genetics (IRD) stock?

Opus Genetics has a consensus price target of $7.33.

What is the current price for Opus Genetics (IRD)?

The stock price for Opus Genetics (NASDAQ: IRD) is $0.7449 last updated April 14, 2025 at 9:24 AM EDT.

Does Opus Genetics (IRD) pay a dividend?

There are no upcoming dividends for Opus Genetics.

When is Opus Genetics (NASDAQ:IRD) reporting earnings?

Opus Genetics’s Q1 earnings are confirmed for Thursday, May 15, 2025.

Is Opus Genetics (IRD) going to split?

There is no upcoming split for Opus Genetics.

What sector and industry does Opus Genetics (IRD) operate in?

Opus Genetics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Opus Genetics Stock Price, Quotes and Forecasts

Opus Genetics (IRD) Forecast